Immune cell infiltration analysis showed that TBC1D22A could promote the enrichment of M2 macrophages in ovarian cancer tissues to exert an immunosuppressive effect, and ultimately promoted the progression of ovarian cancer. This evidence concerns the gene TBC1D22A and ovarian carcinoma.